Project Grant R21DA060442
Award Date
4/15/25
Completion Date
3/31/27
Dollars Obligated
$234K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Oregon, USA
Similar Awards
This federal Project Grant award for $254,250.00, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to delineate the neurological circuits and cell types involved in mediating contextual memories and behaviors related to cocaine addiction and relapse vulnerability. The key products of this 2-year (Jul 2024 - Jun 2026) exploratory research project will be: Detailed characterization of the intrinsic properties...
This $251,250 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to characterize the role of the neuropeptide nociceptin (NOF/Q) in suppressing cocaine reward in the nucleus accumbens region of the brain. The research aims to leverage cutting-edge genetic and optogenetic tools to understand the mechanisms by which NOF/Q signaling modulates cocaine's rewarding effects and identify the...
This $492,000 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to elucidate the genetic and epigenetic mechanisms underlying cocaine addiction using a multidisciplinary approach. The key objectives are to: 1) conduct high-resolution epigenomic profiling to uncover cell-type and circuit-specific changes after cocaine self-administration in mice, 2) leverage the Hybrid Mouse Diversity Panel to...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $180,606 to the Icahn School of Medicine at Mount Sinai to investigate cocaine-induced synaptic proteomic adaptations and their role in drug-seeking and relapse behaviors. The research aims to elucidate the interplay between drug-induced long-term synaptic proteome changes and underlying transcriptional responses within the nucleus accumbens,...
This Project Grant award, with a total funding of $583,040.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will support research at Oregon Health & Science University (OHSU) focused on understanding the persistence of oxycodone craving and nucleus accumbens plasticity in the context of opioid addiction. The key objectives are to: Assess excitatory synaptic transmission, including the role of...
This $134,753 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to determine the mechanisms by which cocaine alters striatal enkephalin levels and the resulting impact on striatal-pallidal circuit activity and cocaine seeking behaviors. The key objectives are to 1) establish the necessity of striatal enkephalin in cocaine-induced adaptations in the striatopallidal circuit through electrophysiology and...
This federal Project Grant award of $180,646 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support an investigation into the molecular mechanisms underlying the regulation of cocaine drug-seeking behavior by astrocytic CREB (cAMP response element-binding protein). The research aims to elucidate the astrocyte transcriptome and its epigenetic regulation in the context of drug addiction, with a focus on uncovering...
This federal Project Grant award for $249,236 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research into the role of chromatin regulation and BDNF expression in the ventral tegmental area of the brain in driving persistent cocaine-seeking behaviors. The study aims to define the chromatin architecture changes in dopamine neurons that occur during forced abstinence from chronic cocaine exposure, and then use...
This federal Project Grant award for $149,284 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to define how chronic cocaine use disrupts the regulation of striatal neural activity by dopamine. The key products and services to be delivered include: Employing single-cell calcium imaging and optogenetic manipulation to establish the temporal parameters under which dopamine release modulates the activity of D1 and D2-containing...
This federal Project Grant award, totaling $373,300.00, was made by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant aims to study the role of the nucleus accumbens core (NAc) in learning the association between environmental cues and rewards, which is critical for understanding substance use disorder. Specifically, the research will use optogenetic inhibition and two-photon imaging techniques in mice to investigate how...